Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 7/20 | 0.48 |
| ▸ | HTR1B | P28222 | 7/20 | 0.48 |
| ▸ | NOS3 | P29474 | 3/20 | 0.41 |
| ▸ | NOS1 | P29475 | 3/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 3/20 | 0.40 |
| ▸ | DRD2 | P14416 | 3/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7001758 | 1.00 | HTR1D (0.48) | HTR1DHTR1BNOS3NOS1NOS2 | |
| SCHEMBL7002581 | 0.81 | SLC6A4 (0.39) | — | |
| SCHEMBL7001453 | 0.81 | SLC6A4 (0.39) | — | |
| SCHEMBL7001456 | 0.81 | SLC6A4 (0.39) | — | |
| SCHEMBL1122232 | 0.81 | HTR1D (0.43) | HTR1DHTR1BNOS3NOS1NOS2 | |
| SCHEMBL6999439 | 0.81 | SLC6A4 (0.56) | HTR1DHTR1B | |
| SCHEMBL6999444 | 0.81 | SLC6A4 (0.56) | HTR1DHTR1B | |
| SCHEMBL7001003 | 0.80 | SLC6A4 (0.38) | — | |
| SCHEMBL1122163 | 0.80 | NOS1 (0.67) | NOS3NOS1NOS2 | |
| SCHEMBL1122161 | 0.80 | NOS1 (0.44) | NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562809-B1 | Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor | NPS ALLELIX CORP. (CA) | 2003-05-13 | — | — | US | claimed |
| EP-1114049-B1 | 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS | NPS ALLELIX CORP (CA) | 2003-03-19 | — | — | EP | claimed |
| US-6562809-B1 | Contraction of coronary arteries may be mediated by its stimulation of the 5-HT1B (formerly 5-HT1D beta); compounds selective for a 5-HT1D receptor | NPS ALLELIX CORP. (CA) | 2003-05-13 | — | — | US | disclosed |
| EP-1114049-B1 | 3-BICYCLOINDOLE COMPOUNDS AS 5-HT1D RECEPTOR LIGANDS | NPS ALLELIX CORP (CA) | 2003-03-19 | — | — | EP | disclosed |